Recognise dangerous upper-body venous congestion, define tumour and thrombus rapidly and coordinate airway, stenting, cancer treatment and device-associated thrombosis care.
SVC obstruction impedes venous return from the head, neck and upper limbs. Symptoms depend on speed, level and collateral formation: rapidly developing thrombotic obstruction can be dramatic, while slowly growing tumour may produce conspicuous collaterals before instability.
Management is determined by severity and cause. Airway or cerebral compromise favours urgent endovascular decompression and critical-care support; a stable patient needs contrast CT and a tissue strategy so that lymphoma, lung cancer and other tumours receive the correct definitive treatment.
Tumour and thrombus frequently coexist. The plan should explicitly state whether anticoagulation is indicated, whether an intravascular device can remain, whether stenting is needed for rapid relief and which specialty owns cancer treatment and follow-up.
Lung cancer, lymphoma and metastatic mediastinal disease may compress or invade the superior vena cava. Tumour-associated hypercoagulability can add intraluminal thrombus, so both mechanisms may coexist.
Peripherally inserted central catheters, tunnelled catheters, ports and pacemaker or defibrillator leads can cause endothelial injury and disturbed flow. Cancer, infection and previous thrombosis further increase device-associated clot risk.
Fibrosing mediastinitis, a large retrosternal goitre, thoracic aneurysmal disease or scarring after thoracic treatment can narrow the vessel externally. Previous instrumentation may also leave chronic central venous stenosis.
External compression, tumour invasion, fixed stenosis or thrombus reduce flow through the superior vena cava. Rapid thrombosis can create severe obstruction before alternative channels enlarge.
Pressure backs up into the brachiocephalic, jugular and upper-limb veins, producing facial, neck and arm oedema, venous plethora and distended, often non-pulsatile neck veins.
Blood is redirected through azygos, intercostal and chest-wall venous channels. Slowly developing disease permits better collateralisation, whereas sudden occlusion tends to produce more dramatic symptoms.
Venous oedema can narrow the upper airway and raise intracranial venous pressure; severe obstruction may also reduce cardiac preload. Stridor, confusion, syncope or hypotension can therefore reflect dangerous physiology and require urgent assessment.
Facial/periorbital and neck swelling, bilateral arm or breast swelling, cyanotic plethora, raised non-pulsatile neck veins and dilated chest-wall collaterals; often worse supine or on bending forward.
Dyspnoea, cough, hoarse voice, dysphagia and orthopnoea may reflect venous oedema, tumour compression, pleural effusion or coexisting airway disease.
Stridor, laryngeal oedema, inability to lie flat, severe work of breathing or rapidly increasing neck swelling requires immediate airway/critical-care and interventional discussion.
Severe headache, visual disturbance, confusion, reduced consciousness, syncope, hypotension or renal hypoperfusion suggests critical venous obstruction.
Smoking history, weight loss, cough/haemoptysis, lymphadenopathy, known lung cancer, lymphoma, metastatic disease or a mediastinal mass.
PICC, tunnelled line, port, dialysis catheter, pacemaker/ICD leads, recent line dysfunction, unilateral arm onset, arm/neck pain or previous thrombosis; infection and cancer can coexist.
Heart failure can cause raised JVP and oedema, but pulmonary congestion, dependent leg swelling and a pulsatile venous waveform are more typical than facial plethora and chest-wall collaterals.
Rapid lip, tongue or facial swelling with urticaria, wheeze or systemic hypotension suggests an allergic process. Distended neck veins and established venous collaterals instead favour central obstruction.
Isolated axillary or subclavian thrombosis usually causes unilateral arm pain and swelling. Bilateral upper-body congestion or a negative peripheral duplex does not exclude more central SVC disease.
Renal failure, nephrotic syndrome or severe hypoalbuminaemia produces more generalised or dependent oedema. Urine and blood findings, leg involvement and absence of chest collaterals help discriminate.
A mediastinal mass may cause cough, dysphagia or stridor without venous obstruction. Contrast CT can show whether airway or oesophageal compression, SVC narrowing and superimposed thrombus are isolated or coexist.
Progressive pharyngeal or laryngeal venous oedema can produce hoarseness, stridor and inability to lie flat. Rapid deterioration may make imaging or airway intervention hazardous without critical-care planning.
Raised intracranial venous pressure can cause severe headache, visual disturbance, confusion, reduced consciousness or seizures. These features indicate critical obstruction requiring immediate multidisciplinary escalation.
Severe obstruction can limit venous return to the right atrium, reducing cardiac preload and output. Hypotension, syncope or renal hypoperfusion signal circulatory involvement but should also prompt assessment for pulmonary embolism, tamponade, sepsis and other coexisting shock mechanisms.
Device-related or tumour-associated thrombus may extend into brachiocephalic and upper-limb veins, threaten vascular access or embolise to the lungs, complicating anticoagulation and intervention planning.
Airway, cerebral or haemodynamic compromise dictates urgent decompression even before the tumour type or complete thrombotic mechanism is known.
Look for both the compressing/invasive mass and superimposed thrombus; treating only one mechanism can leave symptoms unresolved.
Rapid endovascular relief can be followed by biopsy, chemotherapy or radiotherapy and is especially useful when symptoms are severe or the cancer response will not be immediate.
A required, functioning, uninfected catheter may remain during anticoagulation; removal can jeopardise access and does not itself treat central thrombus.
They may reduce oedema in selected malignant obstruction but can alter lymphoma histology and should never delay CT, tissue planning or stent discussion.
It can identify accessible jugular/axillary/subclavian thrombosis but cannot reliably exclude brachiocephalic or SVC obstruction.
Sending a patient with stridor or confusion for unmonitored imaging before airway/critical-care escalation.
Ordering only a chest radiograph or upper-limb ultrasound and treating a negative result as exclusion of SVC disease.
Starting tumour-specific radiotherapy without tissue planning in a stable undiagnosed patient when biopsy is feasible.
Giving corticosteroids reflexively before discussing possible lymphoma histology with haematology/oncology.
Automatically removing a needed, functioning, uninfected catheter instead of anticoagulating and applying guideline removal criteria.
Your practice draft is saved in this browser.
A stable patient has progressive facial and bilateral arm swelling, dilated chest-wall veins and dyspnoea worse when lying flat. What is the best initial investigation to define the suspected obstruction and its cause?
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem ·
Discuss urgently with oncology/haematology, particularly before biopsy when lymphoma is possible because steroids can obscure histology. Monitor glucose, infection, mental state and GI risk; taper as symptoms improve and review stopping if no response after about 7 days.
Review need when steroids stop; consider interactions and alternative lansoprazole 30 mg once daily where appropriate.
Use actual weight; enoxaparin is not recommended when creatinine clearance is below 15 mL/min outside prevention of thrombus in the extracorporeal dialysis circuit. Check platelets, bleeding, recent procedures and previous HIT. Cancer type, thrombocytopenia, drug interactions and planned biopsy/stenting may favour a different LMWH or DOAC strategy after specialist review.